%0 Journal Article %T Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. %A van den Berg MC %A Berg HF %A Stokowy T %A Hoivik EA %A Woie K %A Engerud H %A Ojesina AI %A Haldorsen IS %A Trovik J %A Bertelsen BI %A Krakstad C %A Halle MK %J Int J Gynecol Cancer %V 34 %N 7 %D 2024 Jul 1 %M 38950928 %F 4.661 %R 10.1136/ijgc-2024-005377 %X OBJECTIVE: Although early-detected cervical cancer is associated with good survival, the prognosis for late-stage disease is poor and treatment options are sparse. Mismatch repair deficiency (MMR-D) has surfaced as a predictor of prognosis and response to immune checkpoint inhibitor(s) in several cancer types, but its value in cervical cancer remains unclear. This study aimed to define the prevalence of MMR-D in cervical cancer and assess the prognostic value of MMR protein expression.
METHODS: Expression of the MMR proteins MLH-1, PMS-2, MSH-2, and MSH-6 was investigated by immunohistochemical staining in a prospectively collected cervical cancer cohort (n=508) with corresponding clinicopathological and follow-up data. Sections were scored as either loss or intact expression to define MMR-D, and by a staining index, based on staining intensity and area, evaluating the prognostic potential. RNA and whole exome sequencing data were available for 72 and 75 of the patients and were used for gene set enrichment and mutational analyses, respectively.
RESULTS: Five (1%) tumors were MMR-deficient, three of which were of neuroendocrine histology. MMR status did not predict survival (HR 1.93, p=0.17). MSH-2 low (n=48) was associated with poor survival (HR 1.94, p=0.02), also when adjusting for tumor stage, tumor type, and patient age (HR 2.06, p=0.013). MSH-2 low tumors had higher tumor mutational burden (p=0.003) and higher frequency of (frameshift) mutations in the double-strand break repair gene RAD50 (p<0.01).
CONCLUSIONS: MMR-D is rare in cervical cancer, yet low MSH-2 expression is an independent predictor of poor survival.